Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins
- 1 November 1986
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 141 (1), 33-38
- https://doi.org/10.1016/s0006-291x(86)80330-8
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- 2-Deoxy-d-glucose inhibition of herpes simplex virus type-1 receptor expressionAntiviral Research, 1986
- Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 MoleculeScience, 1986
- Identification and antigenicity of the major envelope glycoprotein of of lymphadenopathy-associated virusVirology, 1985
- Inhibition of synthesis of herpesvirus (HSV-1) glycoproteins and endogenous fusion by β-hydroxynorvaline in BHK-21 cellsVirology, 1984
- Isolation of Human T-Cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- A study of the antiviral mechanism of action of 2-deoxy-d-glucose: Normally glycosylated proteins are not strictly required for herpes simplex virus attachment but increase viral penetration and infectivityVirology, 1982
- Pneumocystis cariniiPneumonia and Mucosal Candidiasis in Previously Healthy Homosexual MenNew England Journal of Medicine, 1981
- Glucose analogues in the chemotherapy of herspesvirus infectionsPharmacology & Therapeutics, 1980
- Effect of 2-deoxy-D-glucose on cell fusion induced by Newcastle disease and Herpes simplex virusesVirology, 1973